Eva Maria Herold
Papers
1
Total Citations
22
H-Index
1
About
Eva Maria Herold is a leading researcher in biopharmaceutical characterization, with a primary focus on the analysis of protein aggregates and sub-visible particles in monoclonal antibody (mAb) formulations. Her most notable contribution is the development of a high-throughput method using automated fluorescence microscopy imaging to detect and quantify sub-visible mAb aggregate particles, a critical advancement for ensuring the safety and efficacy of therapeutic proteins. This work, published in 2017 and cited 22 times, has provided the biopharmaceutical industry with a powerful tool for rapid, reliable particle analysis, addressing a key challenge in drug development and quality control. Herold's research bridges the gap between advanced imaging techniques and practical pharmaceutical applications, enabling more efficient screening of protein stability and aggregation. Her achievements are particularly valuable for researchers and students in pharmaceutical sciences, biophysics, and bioengineering, as her methods streamline the assessment of complex protein formulations. Through her innovative approach, Herold has made a lasting impact on the field, helping to improve the characterization of biotherapeutics and supporting the development of safer, more effective drugs.
Research Focus
Key Achievements
Top Papers
- 1